Caris Life Sciences Growth Equity

Caris Life Sciences provides comprehensive molecular profiling services that analyze DNA, RNA, and proteins to reveal a molecular blueprint. This information informs personalized treatment decisions for patients and physicians, and supports precision oncology programs for biopharma partners. They aim to improve the human condition by understanding the molecular errors that cause disease.